Clinical trial
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of Anrikefon for Perioperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy (PCNL)
NCT07825142 is registered in ClinicalTrials.gov with Beijing Tsinghua Chang Gung Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of Anrikefon for Perioperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy (PCNL)
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 12, 2026
- Completion date
- December 30, 2029
- Enrollment
- 160 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.